Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy.
暂无分享,去创建一个
R. Porcher | C. Delaugerre | J. Molina | C. Torti | A. Ammassari | A. Castagna | S. Rusconi | N. Valin | J. Ghosn | J. Pavie | J. Medrano